Kitman Labs, a sports analytics and technology company, recently announced a successful Series C funding round, raising $52 million. This funding round was led by Zouk Capital, with additional investments from rival technology companies.
The new capital will enable the company to scale its operations and expand its customer base.
This article will provide an in-depth analysis of Kitman Labs’ Series C funding round.
Background of Kitman Labs
Kitman Labs, an industry-leading sports performance and injury prevention technology provider founded in 2014, has announced its Series C funding round totaling $52 million. The investment was provided by Insight Venture Partners, bringing the company’s total funding amount to over $90 million.
The company’s platform provides teams with a comprehensive suite of tools for sports performance management, athlete wellbeing assessment, and injury risk monitoring. In addition, Kitman Labs focuses on creating a connected data experience – enabling teams to get all the relevant data in one place and act on it quickly. This latest round of funding leverages the wealth of data they have collected across professional athletes in sports including basketball, football, soccer, baseball and more.
Headquartered in Dublin, Ireland, Kitman Labs also has regional offices located in San Francisco (United States), Panjin (China) and Caracas (Venezuela). The company’s clients include some of the biggest names in global sport including Tottenham Hotspur FC (English Premier League Football), Real Madrid CF (La Liga Football), Los Angeles Lakers (NBA Basketball) and Cristiano Ronaldo-affiliated Pestana Football Club (Portuguese professional football).
Overview of Series C Funding Round
Kitman Labs, the leader in performance optimization for elite athletes, announced it has closed a $52 million Series C funding round. This round was co-led by Europe’s Atomico and fellow existing investors M12—Microsoft’s Venture Fund—and Celtic House. This brings Kitman Labs’ total investment to $77 million and marks the completion of their Series C funding which began in March 2020.
This investment will enable Kitman Labs to continue building out its platform and expanding its offering to current and future customers, as it continues its work to bring cutting edge technology solutions to elite sports organisations worldwide. This latest injection of funds is set to bring more advanced artificial intelligence (AI) solutions and data delivery capabilities while driving real-time athlete performance optimization through Kitman’s market-leading technologies. Meanwhile the global elite athletic community will continue receiving ongoing upskilling in sporting science from Kitman Labs’ industry experts.
Impact of Funding
Kitman Labs, a sports analytics and technology company, recently announced that it has raised $52 million in its Series C funding round. This funding round was backed by several well-known firms, including Salesforce Ventures, Fidelity International, and ShineWing International. This financial support enables Kitman Labs to expand into new markets and invest in its core product offerings, which will significantly impact the company’s future growth.
This article will discuss the implications of this funding for Kitman Labs.
Expansion of Kitman Labs
Kitman Labs, a digital health and sports performance platform provider, recently announced it had raised $52 million in its Series C funding round. The round was co-led by Endeavor Catalyst and PSP Investments and saw participation from several other notable investors. This brings the total capital Kitman has raised to date to $90 million.
With this new funding, the company plans to expand its services worldwide. It will focus on leveraging artificial intelligence (AI) technology across sports performance to enhance athlete safety protocols and improve injury intelligence collection and decision-making capabilities. Furthermore, it will strive to develop an enhanced ecosystem of health collaboration that leverages innovative data science algorithms and patented innovation technologies.
The team is also looking at specific investments in research & development (R&D), sales expansion, strategic partnerships, international growth, product expansion including integration with additional third party solutions, and cybersecurity enhancements that will extend their protection against data privacy concerns from customers. Overall this creates a powerful opportunity for Kitman Labs to reach new milestones within digital healthcare practice solutions for athletes worldwide.
Kitman Labs, A Sports Analytics And Technology Company, Raises $52 Million Series C Funding Round
Kitman Labs, a sports technology company, has secured $52 million in Series C funding. This marks the company’s third investment round, bringing their total capital to over $100 million. The new funding will help the company expand its products and services more broadly into the global market.
Columbus Nova Technology Partners led the investment with participation from existing investors including Sapphire Ventures (formerly SAP Ventures). Other strategic partners have also participated in the round. According to Kitman Labs CEO Iarfhlaith Kelly, “More than ever, organisations are focused on performance and are willing to invest in technology that can improve results. As a result, we’ve seen multiple sport teams working with our platform achieve improved performance outcomes, reduced injuries, and improved athlete availability.”
In addition to expanding its existing product offerings, Kitman Labs plans to use the new funds to research and develop new products and sales, marketing, customer engagement initiatives and support efforts. The firm noted that their technology offers clients a highly customizable system for managing doctor’s appointments, analytics data collection along with tracking team practices. Utilising Kitman’s platform in this manner allows skills coaches in various sectors such as sports or healthcare to understand team strategies more accurately and make meaningful adjustments accordingly.
Investors
Kitman Labs, a sports analytics and technology company, has raised $52 million in a Series C funding round. The round was led by Breed Reply and Beringea and joined by prominent investors such as Emerge, M12, Barclays and Dogpatch Labs. This brings the total funding raised by the company to date to $85 million.
Investors have certainly seen the potential of Kitman Labs, and this funding round is a testament to the company’s growth and future development. Let’s take a closer look at who the investors are and what their involvement in the company may mean.
Lead Investor
Kitman Labs, a sports performance platform company, recently announced that it has raised $52 million in a Series C funding round led by New York-based Lone Pine Capital. This is the second major capital raise since Kitman Labs was founded five years ago in 2014. This funding round brings Kitman Labs’ total equity funding to $111 million.
The Series C financing will be used to further develop and scale Kitman Lab’s performance optimization technology, allowing coaches and athletes to quickly assess injury risks, plan training regimens, and monitor teams’ progress remotely. By leveraging data from fitness trackers, sensors and wearables, this technology helps professional coaches and athletes identify problems early on and focus on workouts that yield the highest results.
In addition to Lone Pine Capital’s leading role in the funding round, other key investors include SVB Capital, M13 Ventures, Greenfield Partners Limited as well as Jerusalem-based Qumra Capital Management — all of whom participated in previous rounds of financing as well as new investors such as Energy Impact Partners (EIP).
Commenting on its latest infusion of cash funds, Kitman Labs CEO Stephen Smith said: “We’re proud of our success in developing cutting-edge tools for coaches and athletes that are making sports performance more accessible than ever before. We’ve been looking forward to this next growth stage with our partners at Lone Pine Capital and are thankful for their support”.
Other Investors
Kitman Labs’ Series C funding round was led by Google-affiliated venture firm humongous Ventures, with participation from existing investors Drive Capital and Polaris Partners. The company also saw support from a host of other venture capital (VC) firms like Octopus Ventures, Eclipse Ventures, Silicon Valley Bank and SignalFire, who all participated in the round to help Kitman Labs reach its goal.
In addition to the venture capital firms listed above, leading international sports organisations also shared their support for the latest funding round. Investing organisations included: Inter Milan Football Club, Los Angeles Dodgers Major League Baseball Team and Player’s Health Technology Fund. Moreover, the company also welcomed two European soccer players as inaugural private investors for this latest round.
Kitman’s Series C funding showed tremendous market validation of their performance optimization solutions among sports organisations worldwide. In addition, it showcased broad investor interest in supporting the continued growth of their enterprise software solutions. With this new set of resources now available to Kitman Labs, they plan on accelerating their product roadmap while continuing to scale up new customer acquisition initiatives — particularly across Europe where the business has seen an exponential growth trajectory over recent quarters.
Benefits of Kitman Labs
Kitman Labs, a sports analytics and technology company, recently raised $52 million in Series C funding round. This gives the company greater access to resources, new technologies, and growth opportunities.
This section will cover the benefits Kitman Labs will gain from the Series C funding.
Improved Performance
The software solutions developed by Kitman Labs significantly improve performance in team sports. With Kitman Labs, teams can collect, analyse and act on data faster than ever. The platform’s range of machine learning algorithms quickly identifies trends. It provides recommendations to help coaches and managers better understand their athletes’ performance while giving them a competitive edge in the field.
Kitman Labs simplifies the thousands of data points that manually need to be analysed when tracking an athlete’s progress. It accurately models relevant contextual information about an athlete including biometrics, movement, nutrition and training load to better understand their maintenance needs and winning strategies.
As a result, athletes can perform at peak levels for longer periods due to better preparedness in training, consistent team line-ups, improved tactics from machine learning insights, better facilities management—all with the aim of injury prevention and maximising team performance on game day.
Improved Injury Prevention
Kitman Labs helps athletes, teams and coaches make proactive decisions to reduce the chance of injury. The company provides insight on athletes’ performance and helps anticipate risk factors accurately.
Kitman’s technology can help alert coaches when an athlete is at a higher risk of injury. They can take proactive steps to change practice drills or modify weight training regimens accordingly to help avoid long-term injuries.
Kitman also has tools for tracking performance health metrics that allow users to track a player’s training load and fatigue levels over time, providing coaches with the data needed for understanding the cause of a potential injury and the ability to implement preventative measures. With daily, objective performance metrics from Kitman Labs, teams will have predictive indicators for improved injury prevention and deeper analytics into all aspects of team health.
This technology allows teams to monitor athletes’ workloads to keep them strong while reducing their risk of injuries while competing at high levels.
tags = Kitman Labs, Sports Analytics And Technology Company, Raises $52 Million, 700 college and professional teams, kitman labs series guggenheim investments 82mcaseyforbes, kitman labs ai 52m guggenheim 82mcaseyforbes, Guggenheim Investments
